Literature DB >> 765163

Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system.

A Nasjletti, J Colina-Chourio.   

Abstract

Kinins and prostaglandins of the E series (PGE) have the capacity to influence renal hemodynamic and excretory events and may interact intrarenally so as to reinforce one another. Thus, in the isolated Krebs-perfused rabbit kidney we showed that addition of either bradykinin or kininogen to the perfusing fluid augments the release of a PGE-like substance and that aprotinin, a kallikrein inhibitor, reduces the release of prostaglandins evoked by kininogen but not by bradykinin. Moreover, we have observed that deoxycorticosterone, an agent which increases urinary kallikrein, enhances the urinary excretion of PGE-like substance, and that this effect is prevented by simultaneous treatment with aprotinin. These observations and our demonstration that enhanced intrarenal activity of the kallikrein-kinin system, consequent to kininase II inhibition, is associated with renal vasodilation, diuresis, and natriuresis, suggest that a coupling of kinins and prostaglandins intrarenally may be directed towards the facilitation of salt-water excretion. The interdigitation of prostaglandins and the kallikrein-kinin system may thereby constitute the essential operation of a regulatory system in which the complementary actions of these hormones antagonize the sodium retaining effect of mineralocorticoids in those states in which salt-water balance is positive.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 765163

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  12 in total

1.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

Authors:  S B Levy; J J Lilley; R P Frigon; R A Stone
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin.

Authors:  R M Zusman; H R Keiser
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Inhibition of transmitter release from isolated rabbit kidney by bradykinin.

Authors:  R K Türker; Z S Ercan
Journal:  Agents Actions       Date:  1977-10

Review 4.  The kallikrein-kinin system in circulatory and metabolic homeostasis.

Authors:  R McConn; G L Haberland; J C Frölich
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

5.  The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.

Authors:  J M Vinci; J R Gill; R E Bowden; J J Pisano; J L Izzo; N Radfar; A A Taylor; R M Zusman; F C Bartter; H R Keiser
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

Review 6.  [Prostaglandins in cardiovascular and renal function. Biochemical, physiological and clinical findings (author's transl)].

Authors:  P C Weber; W Siess; B Scherer
Journal:  Klin Wochenschr       Date:  1979-05-03

7.  Attenuation by bradykinin of adrenergically-induced vasoconstriction in the isolated perfused kidney of the rabbit: relationship to prostaglandin synthesis.

Authors:  K U Malik; A Nasjletti
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

8.  The effect of angiotensin I converting enzyme inhibitor (SQ 20881) on the release of prostaglandins by rabbit kidney, in vivo.

Authors:  E J Johns; R Murdock; B Singer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

9.  Kallikrein stimulates arachidonic acid release and production of prostaglandins from TEA3A1 endocrine thymic epithelial cells.

Authors:  L Sun; A Piltch; J Hayashi
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

Review 10.  [Renal kallikrein-kinin system and control of blood pressure (author's transl)].

Authors:  A Distler; H P Wolff
Journal:  Klin Wochenschr       Date:  1979-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.